The estimated Net Worth of Thomas James Gunderson is at least $3.96 Million dollars as of 4 March 2024. Mr. Gunderson owns over 25,000 units of Merit Medical Systems stock worth over $3,634,770 and over the last 6 years he sold MMSI stock worth over $0. In addition, he makes $329,900 as Independent Director at Merit Medical Systems.
Sign up
Mr. Gunderson MMSI stock SEC Form 4 insiders trading
Thomas has made over 1 trades of the Merit Medical Systems stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of MMSI stock worth $860,000 on 4 March 2024.
The largest trade he's ever made was exercising 25,000 units of Merit Medical Systems stock on 4 March 2024 worth over $860,000. On average, Thomas trades about 1,667 units every 0 days since 2018. As of 4 March 2024 he still owns at least 37,414 units of Merit Medical Systems stock.
You can see the complete history of Mr. Gunderson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Gunderson biography
Thomas James Gunderson serves as Independent Director of the Company. He is the Chair of the Board of Directors of the Minneapolis Heart Institute Foundation, 2015 to present Executive in Residence at the University of Minnesota’s Medical Industry Leadership Institute, 2016 to present Member of American Heart Association Science and Technology Accelerator Committee, 2015 to 2017 Managing Director and senior research analyst at Piper Jaffray (focus on medical technology companies), 1992 to 2016 Project Director at American Medical Systems (private medical device company acquired by Pfizer in 1983), 1979 to 1992 Recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, Thomson Reuters, and Medical Device and Diagnostic Industry (e.g., in 1996 and 2000, he was named an All-Star Analyst for medical stocks by the Wall Street Journal and in 2014, Thomson-Reuters named him “Top Stock Picker” in the medical technology sector). Mr. Gunderson provides the Board with more than 25 years of substantive experience in the medical device industry, with a seasoned perspective on the challenges, trends and opportunities of publicly-traded medical device manufacturers, as well as a keen understanding of the Company’s competitive position within its industry. Mr. Gunderson also contributes a strong background in financial and economic analysis and valuable insights regarding business development and acquisition opportunities. Mr. Gunderson’s financial background and industry experience have been beneficial in his service as the Chair of our newly-established Finance Committee.
What is the salary of Thomas Gunderson?
As the Independent Director of Merit Medical Systems, the total compensation of Thomas Gunderson at Merit Medical Systems is $329,900. There are 11 executives at Merit Medical Systems getting paid more, with Fred Lampropoulos having the highest compensation of $5,049,290.
How old is Thomas Gunderson?
Thomas Gunderson is 69, he's been the Independent Director of Merit Medical Systems since 2017. There are 3 older and 13 younger executives at Merit Medical Systems. The oldest executive at Merit Medical Systems, Inc. is A. Scott Anderson, 73, who is the Independent Director.
What's Thomas Gunderson's mailing address?
Thomas's mailing address filed with the SEC is C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER, MA, 01810.
Insiders trading at Merit Medical Systems
Over the last 24 years, insiders at Merit Medical Systems have traded over $17,410,674 worth of Merit Medical Systems stock and bought 12,774 units worth $365,476 . The most active insiders traders include Fred P Lampropoulos, Kent W Stanger, and A Scott Anderson. On average, Merit Medical Systems executives and independent directors trade stock every 24 days with the average trade being worth of $1,968,745. The most recent stock trade was executed by F. Ann Millner on 28 June 2024, trading 12,500 units of MMSI stock currently worth $631,250.
What does Merit Medical Systems do?
merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c
What does Merit Medical Systems's logo look like?
Complete history of Mr. Gunderson stock trades at Merit Medical Systems and TransMedics
Merit Medical Systems executives and stock owners
Merit Medical Systems executives and other stock owners filed with the SEC include:
-
Fred Lampropoulos,
Chairman of the Board, President, Chief Executive Officer -
Fred P. Lampropoulos,
Founder, Chairman, CEO & Pres -
Joseph Wright,
President - International Division -
Ronald Frost,
Chief Operating Officer -
Justin Lampropoulos,
Executive Vice President - Sales, Marketing and Strategy -
Brian Lloyd,
Chief Legal Officer, Corporate Secretary -
Raul Parra,
Chief Financial Officer, Treasurer -
Ronald A. Frost,
Chief Operating Officer -
Raul Parra Jr., CPA,
CFO & Treasurer -
Brian G. Lloyd,
Chief Legal Officer & Corp. Sec. -
Jill Anderson,
Independent Director -
Thomas Gunderson,
Independent Director -
A. Scott Anderson,
Independent Director -
F. Ann Millner,
Independent Director -
Lynne Ward,
Director -
Anne-Marie Wright,
Vice President - Corporate Communications -
Dr. Nicole Priest,
Chief Wellness Officer -
Neil Peterson,
Chief Operating Officer -
Joseph C. Wright,
Pres of International Division -
John Knorpp,
Chief Regulatory Affairs Officer -
Michel J. Voigt,
Chief HR Officer -
Joseph Pierce,
Chief Information Officer -
Jason Treft,
Chief Technology Officer -
Franklin J Miller,
-
Bernard Birkett,
Chief Financial Officer -
Kent W Stanger,
Chief Financial Officer -
Michael E Stillabower,
Director -
Richard W Edelman,
Director -
Silvia Perez,
-
Elizabeth Huebner,
Director -
Greg L Barnett,
-
Arlin D Nelson,
Chief Operating Officer -
Rashelle Perry,
Chief Legal Officer -
Martin R Stephens,
VP of Sales -
Brian L Ferrand,
Director of Sales -
B Leigh Weintraub,
Vice President - Operations -
Rex C Bean,
Director -
James J Ellis,
Director -
Laura S. Kaiser,
-
Stephen C. Evans,
-
Nolan E. Karras,
-
David Ming Teh Liu,
-
Lonny J Carpenter,
-
David Floyd,
-
James T. Hogan,
-
Michel James Voigt,
CHIEF HUMAN RESOURCES OFFICER -
Michael R Mcdonnell,
-
Neil Peterson,
CHIEF OPERATING OFFICER